» Articles » PMID: 37460667

Identity, Structure, and Function of the Mitochondrial Permeability Transition Pore: Controversies, Consensus, Recent Advances, and Future Directions

Overview
Specialty Cell Biology
Date 2023 Jul 17
PMID 37460667
Authors
Affiliations
Soon will be listed here.
Abstract

The mitochondrial permeability transition (mPT) describes a Ca-dependent and cyclophilin D (CypD)-facilitated increase of inner mitochondrial membrane permeability that allows diffusion of molecules up to 1.5 kDa in size. It is mediated by a non-selective channel, the mitochondrial permeability transition pore (mPTP). Sustained mPTP opening causes mitochondrial swelling, which ruptures the outer mitochondrial membrane leading to subsequent apoptotic and necrotic cell death, and is implicated in a range of pathologies. However, transient mPTP opening at various sub-conductance states may contribute several physiological roles such as alterations in mitochondrial bioenergetics and rapid Ca efflux. Since its discovery decades ago, intensive efforts have been made to identify the exact pore-forming structure of the mPT. Both the adenine nucleotide translocase (ANT) and, more recently, the mitochondrial FF (F)-ATP synthase dimers, monomers or c-subunit ring alone have been implicated. Here we share the insights of several key investigators with different perspectives who have pioneered mPT research. We critically assess proposed models for the molecular identity of the mPTP and the mechanisms underlying its opposing roles in the life and death of cells. We provide in-depth insights into current controversies, seeking to achieve a degree of consensus that will stimulate future innovative research into the nature and role of the mPTP.

Citing Articles

Exploring Metabolic Shifts in Kidney Cancer and Non-Cancer Cells Under Pro- and Anti-Apoptotic Treatments Using NMR Metabolomics.

Trisolini L, Musio B, Teixeira B, Sgobba M, Francavilla A, Volpicella M Cells. 2025; 14(5).

PMID: 40072095 PMC: 11899725. DOI: 10.3390/cells14050367.


Aerosolized nicotine-free e-liquid base constituents exacerbates mitochondrial dysfunction and endothelial glycocalyx shedding via the AKT/GSK3β-mPTP pathway in lung injury models.

Dai Z, Xie B, Jiang C, Peng Y, Lin J, Chen Q Respir Res. 2025; 26(1):82.

PMID: 40025534 PMC: 11871641. DOI: 10.1186/s12931-025-03155-3.


Bioactivity and Neuroprotective Effects of Extra Virgin Olive Oil in a Mouse Model of Cerebral Ischemia: An In Vitro and In Vivo Study.

Scacco S, Acquaviva S, Franca Vieira E Silva F, Zhang J, Lo Muzio L, Corso G Int J Mol Sci. 2025; 26(4).

PMID: 40004234 PMC: 11855186. DOI: 10.3390/ijms26041771.


Mechanisms of Mitochondria-Mediated Apoptosis During Infection.

Bai R, Wang H, Yang T, Yan Y, Zhu S, Lv C Animals (Basel). 2025; 15(4).

PMID: 40003058 PMC: 11852116. DOI: 10.3390/ani15040577.


Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cells.

Whitehead M, Harvey J, Sladen P, Becchi G, Singh K, Sun Y Acta Neuropathol Commun. 2025; 13(1):28.

PMID: 39948685 PMC: 11823152. DOI: 10.1186/s40478-025-01942-z.


References
1.
Halestrap A, Pereira G, Pasdois P . The role of hexokinase in cardioprotection - mechanism and potential for translation. Br J Pharmacol. 2014; 172(8):2085-100. PMC: 4386983. DOI: 10.1111/bph.12899. View

2.
Dovey C, Diep J, Clarke B, Hale A, McNamara D, Guo H . MLKL Requires the Inositol Phosphate Code to Execute Necroptosis. Mol Cell. 2018; 70(5):936-948.e7. PMC: 5994928. DOI: 10.1016/j.molcel.2018.05.010. View

3.
Wang H, Sun L, Su L, Rizo J, Liu L, Wang L . Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014; 54(1):133-146. DOI: 10.1016/j.molcel.2014.03.003. View

4.
Zulian A, Schiavone M, Giorgio V, Bernardi P . Forty years later: Mitochondria as therapeutic targets in muscle diseases. Pharmacol Res. 2016; 113(Pt A):563-573. DOI: 10.1016/j.phrs.2016.09.043. View

5.
Wrogemann K, Pena S . Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Lancet. 1976; 1(7961):672-4. DOI: 10.1016/s0140-6736(76)92781-1. View